Pharmacology, Toxicology and Pharmaceutical Science
Antimalarial Agent
100%
Trypanosoma
52%
Plasmodium falciparum
47%
Mouse
46%
Artemisinin
42%
Pharmacokinetics
37%
Dimer
35%
DNA Topoisomerase
33%
Trypanosoma Brucei
30%
Antitrypanosomal
27%
Broccoli
23%
African Trypanosomiasis
23%
Chemotherapy
20%
Mefloquine
19%
Pharmacodynamics
19%
Isothiocyanate
18%
Plasmodium
17%
Quinolone Derivative
17%
Sulfone
17%
Atovaquone
17%
Antiinfective Agent
17%
Drug Resistance
17%
Drug Development
15%
Chloroquine
15%
Disease
15%
Benflumetol
15%
Antimalarial Activity
15%
Endoperoxide
14%
Kinetoplast DNA
14%
Camptothecin
13%
Combination Therapy
13%
Protozoon
12%
Mitochondrial DNA
12%
Glucosinolate
12%
Malaria Falciparum
12%
Leishmania
11%
Pleura Mesothelioma
11%
Allopurinol Riboside
11%
DNA Topoisomerase Inhibitor
11%
Nucleic Acid
10%
Dithiocarbamate
10%
Sulforaphane
10%
Heat Shock Protein 90 Inhibitor
9%
Malignant Neoplasm
9%
Carboxylate
8%
Clinical Trial
8%
Artemether Plus Benflumetol
8%
Molecular Target
7%
Deoxyribonucleoprotein
7%
Toxic Injury
7%
Keyphrases
NCCN Guidelines
61%
Non-small Cell Lung Cancer (NSCLC)
53%
Plasmodium Falciparum
52%
Trioxane
38%
Malaria
24%
KDNA
23%
Antimalarial Drugs
21%
Antitrypanosomal Activity
19%
Pharmacokinetics
19%
Minicircle DNA
19%
Camptothecin
18%
Trypanosome
18%
Trypanosoma Brucei
17%
Topoisomerase
16%
Chloroquine
15%
Artemisinin
14%
Topoisomerase Inhibitors
13%
Peroxide
13%
Oncology
12%
Sulfide
12%
Mesothelioma
11%
Rodents
11%
Antimalarial Chemotherapy
11%
Peroxy
11%
Atovaquone
11%
African Trypanosomes
11%
Preclinical Efficacy
11%
Malaria Parasite
10%
Drug Resistance
10%
Targeted Therapy
10%
T. Equiperdum
9%
Metastatic Non-small Cell Lung Cancer
9%
NCCN Clinical Practice Guidelines
9%
Pharmacodynamics
9%
Antiprotozoal
8%
Structure-activity
8%
Water-soluble
8%
Sulfone
8%
Malignant Pleural Mesothelioma
8%
Minicircle
8%
Prophylactic Activity
7%
RNA Interference
7%
Infected Mice
7%
Leishmania
7%
Mitochondrial DNA
7%
Clinically Significant
7%
Recent Update
6%
Bloodstream Forms
6%
Drug Development
6%
Catenanes
6%